New Pill Reduces ‘Bad’ Cholesterol Levels by Almost 60%

Health & LifestyleNews
367

Listen to article (english)

Translate to Spanish or other 102 languages!

The study recruited people with heterozygous familial hypercholesterolemia, a genetic condition that causes the individual to have high levels of LDL, or “bad” cholesterol. Image for illustration purposes
The study recruited people with heterozygous familial hypercholesterolemia, a genetic condition that causes the individual to have high levels of LDL, or “bad” cholesterol. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

A recent study published in JAMA on November 9, investigates a drug called enlicitide. 

The study recruited people with heterozygous familial hypercholesterolemia, a genetic condition that causes the individual to have high levels of LDL, or “bad” cholesterol.

- Advertisement -

For these individuals, lifestyle changes and statins are often inadequate to bring their levels of LDL cholesterol down.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/oral-pill-enlicitide-reduces-bad-cholesterol-levels-statins?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-11-26&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Importance of Knowing Family Health History
Next article
DHR Health Earns an ‘A’ Hospital Safety Grade

More Articles

STHS Heart’s Intensive Cardiac Rehab Program Earns AACVPR Recertification

Each year, more than 800,000 people in the United States experience a heart attack, according to the American Heart Association, and approximately one in four of those events are repeat occurrence

Newly Discovered Genetic Eye Disease Triggers Night Blindness and Tunnel Vision

Scientists identified a new vision condition linked to a gene already connected to a different vision-loss disease. While the previously identified disease causes loss of central vision, the new condition affects peripheral and night vision.

STC Faculty Member Reflects on Remarkable Nursing Career

For 55 years, South Texas College faculty member Sylvia Sandoval has dedicated her life to nursing, from championing women’s health and witnessing the miracle of birth to shaping generations of nurses.

Join NHPO-RGV for an Unforgettable Valley Networking Night, Sept. 17th

Networking is an essential tool for professional success. It helps build meaningful relationships, fosters mentorship and support, encourages the exchange of ideas and industry insights, and creates opportunities for career and business growth.
- Advertisement -